Honestly, running a pharma company in today’s environment is tough. You absolutely have to move fast and be flexible, but the cost of building out the necessary infrastructure is just crushing. Established giants and hungry new startups are both facing the same challenge: how do you expand without literally bankrupting yourself with overhead?